24Indexed trials
canonical disease area
Movement Disorders
Intelligence
Movement Disorders intelligence: 24 indexed trials, 6 recruiting studies, 24 sponsors across 14 countries.
6Recruiting
24Sponsors
14Countries
Leading sponsors
AEON Biopharma, Inc.10 recruiting
AbbVie10 recruiting
Chelsea Therapeutics10 recruiting
Columbia University10 recruiting
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental10 recruiting
Icahn School of Medicine at Mount Sinai10 recruiting
Institut National de la Santé Et de la Recherche Médicale, France10 recruiting
Ipsen10 recruiting
Mashhad University of Medical Sciences10 recruiting
Mayo Clinic11 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)10 recruiting
Oregon Health and Science University11 recruiting
Geographic activity
United States14trials
Canada3trials
Japan2trials
France2trials
Spain2trials
Iran1trials
Italy1trials
Australia1trials
New Zealand1trials
South Korea1trials
Croatia1trials
Switzerland1trials
Leading interventions
Autologous Mesenchymal Stem Cells1trials
BOTOX1trials
Bilateral 1 Hz Cerebellar rTMS1trials
Botulinum toxin type A1trials
Botulinum toxin, type B1trials
Cerebellar repetitive transcranial magnetic stimulation1trials
Change DBS programming1trials
Deep Brain Stimulation (DBS)1trials
Deep Brain Stimulation surgery1trials
Droxidopa1trials
Habituation of velocity storage of the vestibulo-ocular reflex1trials
ABP-4501trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.